The Claim
Colibactin-producing Escherichia coli are associated with the SBS-pks mutation signature in colorectal tumors, and the presence of this mutation signature is significantly more frequent in patients diagnosed with colorectal cancer before age 55 than in those diagnosed at age 59 or older.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Certain strains of E. coli that produce a toxin called colibactin are linked to a specific pattern of DNA damage found in colorectal tumors. This DNA damage pattern is more commonly found in tumors from people diagnosed with colorectal cancer before age 55 compared to those diagnosed at age 59 or older.
See the scientific wording
Colibactin-producing Escherichia coli are associated with a mutation signature (SBS-pks) in colorectal tumors, and tumors bearing this signature are found significantly more often in patients diagnosed with colorectal cancer before age 55 compared to those diagnosed at age 59 or older, suggesting a potential link between this bacterial genotoxin and earlier disease onset.
What the research says
1 studyScientists found that a type of harmful gut bacteria leaves a unique DNA damage pattern in colon tumors, and this pattern shows up much more often in younger people with colon cancer. This suggests the bacteria might help cause cancer to develop earlier in life.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.